Medical r & d contract DHA sbir PH II H2-0648 - field deployable handheld sequencing technology and bioinformatics system for rapid detection of pathogens, AMR, and virulence for clinical…
Ended Definitive Contract Awarded Last action
- Contract number
- W81XWH21C0095
- Awardee
-
Cosmosid, Inc. UEI S1AAT83NPLC4
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $1,099,829
Award facts
- Opportunity
-
- HQ003421R1DSB Solicitation number
- Contract value 100% obligated
- $1,099,829.44 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 3 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Rockville, MD 20850, USA
- Research
- SBIR Program Phase II Action
Award details come from SAM.gov/FPDS.
About this award
The Department of the Army Medical Command awarded a $1.1 million firm fixed price contract to Cosmosid Inc. under a Small Business Innovation Research Program Phase II topic soliciting proposals for a field deployable handheld sequencing technology and bioinformatics system. The system will enable rapid detection of pathogens, antimicrobial resistance, and virulence factors to support clinical decision-making in a battlefield environment. Cosmosid will deliver the requested products and services from their place of performance in Potomac, Maryland over a 27-month period ending in January 2024. The contract is set aside for total small businesses. This award advances the Army's medical research efforts to develop diagnostics supporting deployed healthcare operations in austere conditions.
Description
Medical r & d contract DHA sbir PH II H2-0648 - field deployable handheld sequencing technology and bioinformatics system for rapid detection of pathogens, AMR, and virulence for clinical decision-making in a battlefield environment. Topic DHA201-001
Quick answers
Who was awarded contract W81XWH21C0095?
W81XWH21C0095 was awarded to Cosmosid, Inc. by Medical Command (Department of the Army) on September 8, 2021.
How much is contract W81XWH21C0095 worth?
The government has obligated $1,099,829 on W81XWH21C0095.
Was contract W81XWH21C0095 competed?
The extent of competition for W81XWH21C0095 was full and open competition after exclusion of sources. The government received 3 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award